MetLife, Inc. $MET Position Lowered by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. reduced its position in MetLife, Inc. (NYSE:MET) by 5.7% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 216,500 shares of the financial services provider’s stock after selling 13,200 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in MetLife were worth $17,411,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD raised its position in shares of MetLife by 7.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider’s stock valued at $2,126,734,000 after acquiring an additional 1,824,907 shares in the last quarter. Bank of New York Mellon Corp increased its stake in MetLife by 0.4% during the first quarter. Bank of New York Mellon Corp now owns 8,862,835 shares of the financial services provider’s stock valued at $711,597,000 after purchasing an additional 36,177 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in shares of MetLife by 3.6% during the first quarter. Ameriprise Financial Inc. now owns 7,406,512 shares of the financial services provider’s stock worth $594,410,000 after purchasing an additional 259,993 shares during the period. Northern Trust Corp lifted its position in shares of MetLife by 0.8% in the 1st quarter. Northern Trust Corp now owns 7,109,423 shares of the financial services provider’s stock worth $570,816,000 after buying an additional 57,221 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of MetLife by 3.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 6,671,435 shares of the financial services provider’s stock valued at $535,568,000 after buying an additional 236,698 shares during the period. Institutional investors own 94.99% of the company’s stock.

MetLife Price Performance

Shares of MET opened at $79.13 on Friday. MetLife, Inc. has a one year low of $65.21 and a one year high of $89.05. The stock’s fifty day moving average is $78.27 and its 200-day moving average is $78.17. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a market capitalization of $52.62 billion, a price-to-earnings ratio of 13.41, a price-to-earnings-growth ratio of 0.71 and a beta of 0.87.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.32 by ($0.30). The company had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. During the same quarter in the prior year, the company earned $2.28 EPS. The business’s quarterly revenue was down 2.7% on a year-over-year basis. Equities analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 9th. Investors of record on Tuesday, August 5th were issued a dividend of $0.5675 per share. The ex-dividend date of this dividend was Tuesday, August 5th. This represents a $2.27 annualized dividend and a yield of 2.9%. MetLife’s payout ratio is presently 38.47%.

Analyst Ratings Changes

MET has been the topic of a number of recent research reports. UBS Group cut their target price on shares of MetLife from $94.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, August 7th. Jefferies Financial Group boosted their price objective on MetLife from $100.00 to $103.00 and gave the company a “buy” rating in a research report on Monday, August 11th. Cowen reaffirmed a “buy” rating on shares of MetLife in a research report on Friday, August 22nd. Wall Street Zen cut MetLife from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Finally, Barclays upped their price target on shares of MetLife from $88.00 to $94.00 and gave the stock an “overweight” rating in a research report on Monday, July 7th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $95.55.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.